Liminatus Pharma, Inc Class A Common Stock
Price & Volume
Stats
See more52W Range | $0.61-$33.66 |
Market Cap | $145.1M |
Shares Short | 378,072 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.16 |
News
See moreYahoo Finance • 26 days ago
Liminatus Pharma, Inc. (NASDAQ: LIMN) Signs MOU with Capital Trust Group for USD 30 Million Equity Investment via an earn-out mechanism and Future Strategic Cooperation
Yahoo Finance • 3 months ago
Form 8K Liminatus Pharma Inc For: 25 August
Yahoo Finance • 3 months ago
Wondering what's happening in today's pre-market session?
About
CEO | Mr. Chris Kim J.D., L.L.M. |
Address | 6 Centerpointe Drive, La Palma, CA, United States, 90623 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 0 |
